美国Artium Technologies
2002年3月7日，明尼苏达州Islet Technology公司宣布加州Artium Technologies公司已成为他们的全子公司。Artium公司的总裁Will Bachalo先生将担任Islet公司的副总裁并成为董事会成员，主管科技事物；和Bachalo先生一同加入Islet公司的还有Artium公司的5名科学家和工程技术人员，他们将得到Islet公司的股份。而Artium公司仍将独立拥有从政府等渠道获得资金的权力。
从1998年开始，Bachalo先生就担任Islet的科技顾问。他已获得了美国国立卫生研究院的好几项研究经费。
Artium Technologies公司从事激光诊断产品的研制和开发。Islet Technology公司主要研制能分泌胰岛素的分子移植物。
美国Artium公司的烟雾粒子分析仪, 激光相位多普勒干涉仪PDI（PDPA, PDA）, 激光多普勒测速仪LDV。
Artium Technologies, Inc. was founded with the goal of developing and commercializing advanced laser-based diagnostics for environmental and health related applications. It was founded in 1998 by Dr. Bachalo and other key technical staff from his former company, Aerometrics, Inc. While at Aerometrics, this team invented and successfully commercialized the Phase Doppler Particle Analyzer (PDPA) for characterizing spray drop size distributions, drop dynamics, volume flux, number density, and the gas phase turbulence parameters. Today, this instrument is considered to be the worldwide standard for characterizing sprays in a wide range of environments.

Artium received its first SBIR contract from NASA Lewis in 1998 to support the development of the Laser Induced Incandescence (LII) instrument for soot characterization. Over the next several years, we continued to receive SBIR support from NASA, EPA and NIST to further advance this technology and develop it into a commercial product, the LII-200. Artium also partnered with Islet Technology of Minnesota with the goal of developing islet encapsulation for diabetes cure. With the support of SBIR funding, Artium has also successfully developed and commercialized a line of Phase Doppler Interferometry (PDI) products for spray characterization and has also developed the PDI Cloud Probe.